It is now clear that over recent generations there has been a distinct rise in Type 1 diabetes. You may never have consi…
Research
Did a Common Cholesterol Drug Reverse One Teen’s Type 1 Diabetes?
Did fenofibrate – a common cholesterol drug – reverse one 19-year old woman’s newly diagnosed Type 1 diabetes?
This is t…
Some Hope for Your Beta Cells
We all know that in Type 1 diabetes, the pancreas’ beta cells cease to function. But are they eliminated? Do they die? O…
Type 1 Diabetes Up 30% Since 2017, According to CDC Report
Aaron J. Kowalski, Ph.D., President and CEO of JDRF has issued a statement based on two new reports issued by the Center…
Is Type 1 Diabetes Much More Common than We Think?
Is Type 1 diabetes dramatically more common than is widely understood? That’s the contention of Dr. David Leslie, Profes…
Can Diabetes Drug Trials be Trusted?
Researchers Raise Doubt Over Major Diabetes Drug Trials
The FDA requires pharmaceutical companies developing diabetes dr…
JDRF’s Top 10 Diabetes Advances of 2019
JDRF is calling 2019, “a banner year for Type 1 diabetes breakthroughs.” Check out their list below to find …
Chipping Away at Diabetes Research: An Interview with Dr. Elizabeth Mayer-Davis
The 2019 recipient of the American Diabetes Association Kelly West Award for Outstanding Achievement in Epidemiology tal…
Teplizumab May Delay Onset of Type 1 Diabetes
The results of a promising clinical trial were released earlier this month during the American Diabetes Association’s an…
6 Diabetes Research Studies to Watch in 2019
As medical technology and research continues to make advancements, each new year brings about fresh developments and new…
